TLR4 antagonists (Corixa)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameTLR4 antagonists (Corixa)
Drug Alias NameToll-like receptor-4 antagonist (Corixa)TLR4 antagonists (GlaxoSmithKline)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 4 inhibitors
TargetsToll like receptor 4
Therapy Area/IndicationsInflammationCystic FibrosisInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCorixa Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline PlcCorixa Corp
Active IndicationsN/A
Inactive IndicationsInflammationCystic FibrosisInflammatory Bowel Diseases

Other Information

ATC CodeN/A
Related LinksN/A